M Blichert-Toft - Concepedia

Author

M Blichert-Toft

Also Known As

Blichert-Toft, Mogens, M Blichert-Toft, M. BLICHERT-TOFT, M. BLICHERT‐TOFT, M. Blichert-Toft, M. Blichert-toft, M. Blichert‐Toft, MOGENS BLICHERT-TOFT, MOGENS BLICHERT‐TOFT, MOGENS Blichert‐Toft

202

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Rigshospitalet Danish Breast Cancer Cooperative Group University of Copenhagen Glostrup Hospital

About

M Blichert-Toft is an author at Odense University Hospital specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	43	4.8K
2	Health Sciences	8	8	1.9K
3	Public Health	4	4	430
4	Nursing	2	2	136
5	Engineering	1	1	11

M Blichert-Toft

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Marie Overgaard, Maj‐Britt Jensen, Jens Overgaard, The Lancet Breast OncologyRadiation TherapyMedicineCancer ManagementAdjuvant Tamoxifen	1999	1.6K
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials Adri C. Voogd, Maja Nielsen, Johannes L. Peterse, Journal of Clinical Oncology	2001	560
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist, PubMed UrologyOncologyUrokinase PathwayPlasminogen ActivationEndocrine-related Cancer	1993	390
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. M Blichert-Toft, C. Sainte Rose, J. A. Andersen, PubMed Surgical OncologyBreast OncologyCancer ManagementSurgeryRadiation Medicine	1992	375
Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol M Blichert-Toft, Maja Nielsen, Maria Düring, Acta Oncologica Surgical OncologyInvasive Breast CarcinomaBreast OncologyMedicineBreast Conserving Surgery	2008	294
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) Geertjan van Tienhoven, Adri C. Voogd, Johannes L. Peterse, European Journal of Cancer Surgical OncologyBreast OncologyMedicineCancer RecurrenceLoco-regional Recurrence	1999	216
BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES Carsten Rose, K W Andersen, H.T. Mouridsen, The Lancet Breast OncologyMedicinePharmacologyGynecologyBreast Cancer	1985	209
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study Anne Helene Olsen, Sisse Helle Njor, Ilse Vejborg, BMJ	2005	200
Cardiovascular Events before and after Surgery for Primary Hyperparathyroidism Peter Vestergaard, Charlotte Mollerup, Vibe G. Frøkjær, World Journal of Surgery	2003	176
Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Astrid Morris, Robert D. Morris, J. F. Wilson, PubMed	1997	161

Page 1